Publications 2023

Kjernsholen J, Schou-Bredal I, Kaaresen R, Soberg HL, Sagen A (2023)
A Prospective Intervention Study With 6 Months Follow-up of the Effect of Reablement in Home Dwelling Elderly: Patient-reported and Observed Outcomes
Arch Rehabil Res Clin Transl, 6 (1), 100311
DOI 10.1016/j.arrct.2023.100311, PubMed 38482111

Skjerven HK, Myklebust EM, Korvald C, Stubberud K, Hovda T, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2023)
Long-term follow-up of complex oncoplastic breast-conserving surgery, standard breast conservation and skin-sparing mastectomy in DCIS - a register-based study
Eur J Surg Oncol, 50 (2), 107938
DOI 10.1016/j.ejso.2023.107938, PubMed 38199004

Publications 2022

Skjerven HK, Myklebust EM, Korvald C, Porojnicu AC, Kaaresen R, Hofvind S, Schlicting E, Sahlberg KK (2022)
Oncological outcomes after simple and skin-sparing mastectomy of ductal carcinoma in situ: A register-based cohort study of 576 Norwegian women
Eur J Surg Oncol, 49 (3), 575-582
DOI 10.1016/j.ejso.2022.11.594, PubMed 36509629

Publications 2020

Karesen R, Gisvold SE, Heier HE (2020)
The government's "corona commission" is not very representative and has an incompetent leader
Tidsskr. Nor. Laegeforen., 140 (10), 974

Karesen R, Gisvold SE, Heier HE (2020)
Preparedness and hospital building: what should we learn from COVID-19?
Tidsskr. Nor. Laegeforen., 140 (10), 982-984

Kåresen R, Gisvold SE, Heier HE (2020)
[The Norwegian Government’s ‘coronavirus special committee’ is unrepresentative and its chair is unqualified]
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0446, PubMed 32602330

Kåresen R, Gisvold SE, Heier HE (2020)
[Emergency preparedness and hospital-building: What ought we to learn from COVID-19?]
Tidsskr Nor Laegeforen, 140 (10)
DOI 10.4045/tidsskr.20.0286, PubMed 32602334

Schou-Bredal I, Ekeberg Ø, Kåresen R (2020)
Variability and stability of coping styles among breast cancer survivors: A prospective study
Psychooncology, 30 (3), 369-377
DOI 10.1002/pon.5587, PubMed 33167066

Publications 2019

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Naume B, Nygård JF (2019)
Using clinical cancer registry data for estimation of quality indicators: Results from the Norwegian breast cancer registry
Int J Med Inform, 125, 102-109
DOI 10.1016/j.ijmedinf.2019.03.004, PubMed 30914174

Publications 2017

Aure MR, Vitelli V, Jernström S, Kumar S, Krohn M, Due EU, Haukaas TH, Leivonen SK, Vollan HK, Lüders T, Rødland E, Vaske CJ, Zhao W, Møller EK, Nord S, Giskeødegård GF, Bathen TF, Caldas C, Tramm T, Alsner J, Overgaard J, Geisler J, Bukholm IR, Naume B, Schlichting E et al. (2017)
Integrative clustering reveals a novel split in the luminal A subtype of breast cancer with impact on outcome
Breast Cancer Res, 19 (1), 44
DOI 10.1186/s13058-017-0812-y, PubMed 28356166

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2017)
Better survival after breast-conserving therapy compared to mastectomy when axillary node status is positive in early-stage breast cancer: a registry-based follow-up study of 6387 Norwegian women participating in screening, primarily operated between 1998 and 2009
World J Surg Oncol, 15 (1), 118
DOI 10.1186/s12957-017-1184-6, PubMed 28673296

Kåresen R (2017)
[Not Available]
Tidsskr Nor Laegeforen, 137 (10), 682
DOI 10.4045/tidsskr.17.0339, PubMed 28551949

Publications 2015

Aure MR, Jernström S, Krohn M, Vollan HK, Due EU, Rødland E, Kåresen R, Oslo Breast Cancer Research Consortium (OSBREAC), Ram P, Lu Y, Mills GB, Sahlberg KK, Børresen-Dale AL, Lingjærde OC, Kristensen VN (2015)
Integrated analysis reveals microRNA networks coordinately expressed with key proteins in breast cancer
Genome Med, 7 (1), 21
DOI 10.1186/s13073-015-0135-5, PubMed 25873999

Hartmann-Johnsen OJ, Kåresen R, Schlichting E, Nygård JF (2015)
Survival is Better After Breast Conserving Therapy than Mastectomy for Early Stage Breast Cancer: A Registry-Based Follow-up Study of Norwegian Women Primary Operated Between 1998 and 2008
Ann Surg Oncol, 22 (12), 3836-45
DOI 10.1245/s10434-015-4441-3, PubMed 25743325

Kåresen R, Lunde C (2015)
[Not Available]
Tidsskr Nor Laegeforen, 135 (23-24), 2148-50
DOI 10.4045/tidsskr.15.1176, PubMed 26674034

Silwal-Pandit L, Russnes H, Borgen E, Skarpeteig V, Moen Vollan HK, Schlichting E, Kåresen R, Naume B, Børresen-Dale AL, Farnebo M, Langerød A (2015)
The Sub-Cellular Localization of WRAP53 Has Prognostic Impact in Breast Cancer
PLoS One, 10 (10), e0139965
DOI 10.1371/journal.pone.0139965, PubMed 26460974

Tinholt M, Vollan HK, Sahlberg KK, Jernström S, Kaveh F, Lingjærde OC, Kåresen R, Sauer T, Kristensen V, Børresen-Dale AL, Sandset PM, Iversen N (2015)
Tumor expression, plasma levels and genetic polymorphisms of the coagulation inhibitor TFPI are associated with clinicopathological parameters and survival in breast cancer, in contrast to the coagulation initiator TF
Breast Cancer Res, 17 (1), 44
DOI 10.1186/s13058-015-0548-5, PubMed 25882602

Publications 2014

Sagen A, Kaaresen R, Sandvik L, Thune I, Risberg MA (2014)
Upper limb physical function and adverse effects after breast cancer surgery: a prospective 2.5-year follow-up study and preoperative measures
Arch Phys Med Rehabil, 95 (5), 875-81
DOI 10.1016/j.apmr.2013.12.015, PubMed 24389401

Sauer T, Kåresen R (2014)
The value of preoperative ultrasound guided fine-needle aspiration cytology of radiologically suspicious axillary lymph nodes in breast cancer
Cytojournal, 11, 26
DOI 10.4103/1742-6413.141820, PubMed 25317197

Schou Bredal I, Kåresen R, Smeby NA, Espe R, Sørensen EM, Amundsen M, Aas H, Ekeberg Ø (2014)
Effects of a psychoeducational versus a support group intervention in patients with early-stage breast cancer: results of a randomized controlled trial
Cancer Nurs, 37 (3), 198-207
DOI 10.1097/NCC.0b013e31829879a3, PubMed 23782517

Tinholt M, Viken MK, Dahm AE, Vollan HK, Sahlberg KK, Garred O, Børresen-Dale AL, Jacobsen AF, Kristensen V, Bukholm I, Kåresen R, Schlichting E, Skretting G, Lie BA, Sandset PM, Iversen N (2014)
Increased coagulation activity and genetic polymorphisms in the F5, F10 and EPCR genes are associated with breast cancer: a case-control study
BMC Cancer, 14, 845
DOI 10.1186/1471-2407-14-845, PubMed 25407022

Publications 2013

Hofvind S, Schlichting E, Ursin G, Sebuødegård S, Kåresen R (2013)
[Breast cancer surgery in Norway 1986-2009]
Tidsskr Nor Laegeforen, 133 (15), 1582-6
DOI 10.4045/tidsskr.12.0840, PubMed 23970271

Publications 2012

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of vascular endothelial growth factor and vascular endothelial growth factor receptors 1 and 2 in invasive breast carcinoma: prognostic significance and relationship with markers for aggressiveness
Histopathology, 61 (3), 350-64
DOI 10.1111/j.1365-2559.2012.04223.x, PubMed 22690749

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Holm R, Giercksky KE, Nesland JM (2012)
Expression of cyclooxygenase-2 in invasive breast carcinomas and its prognostic impact
Histol Histopathol, 27 (10), 1315-25
DOI 10.14670/HH-27.1315, PubMed 22936450

Schou Bredal I, Kåresen R, Skaane P, Engelstad KS, Ekeberg Ø (2012)
Recall mammography and psychological distress
Eur J Cancer, 49 (4), 805-11
DOI 10.1016/j.ejca.2012.09.001, PubMed 23021930

Synnestvedt M, Borgen E, Russnes HG, Kumar NT, Schlichting E, Giercksky KE, Kåresen R, Nesland JM, Naume B (2012)
Combined analysis of vascular invasion, grade, HER2 and Ki67 expression identifies early breast cancer patients with questionable benefit of systemic adjuvant therapy
Acta Oncol, 52 (1), 91-101
DOI 10.3109/0284186X.2012.713508, PubMed 22934555

Publications 2011

Bergland A, Thorsen H, Kåresen R (2011)
Effect of exercise on mobility, balance, and health-related quality of life in osteoporotic women with a history of vertebral fracture: a randomized, controlled trial
Osteoporos Int, 22 (6), 1863-71
DOI 10.1007/s00198-010-1435-7, PubMed 21060992

Fjösne HE, Søreide JA, Kåresen R, Lønning PE, Jacobsen AB, Lundgren S, NORWEGIAN BREAST CANCER GROUP (NBCG) (2011)
Hospital volume and prognosis among Norwegian breast cancer patients enrolled in adjuvant trials
Acta Oncol, 50 (7), 1068-74
DOI 10.3109/0284186X.2011.585998, PubMed 21745131

Tveito S, Andersen K, Kåresen R, Fodstad Ø (2011)
Analysis of EpCAM positive cells isolated from sentinel lymph nodes of breast cancer patients identifies subpopulations of cells with distinct transcription profiles
Breast Cancer Res, 13 (4), R75
DOI 10.1186/bcr2922, PubMed 21816090

Publications 2010

Bredal IS, Sandvik L, Karesen R, Ekeberg O (2010)
Prognostic value of health-related quality-of-life parameters in early-stage breast cancer: an 8-year follow-up study
Psychooncology, 20 (10), 1102-7
DOI 10.1002/pon.1822, PubMed 20737644

Effenberger KE, Borgen E, Eulenburg CZ, Bartkowiak K, Grosser A, Synnestvedt M, Kaaresen R, Brandt B, Nesland JM, Pantel K, Naume B (2010)
Detection and clinical relevance of early disseminated breast cancer cells depend on their cytokeratin expression pattern
Breast Cancer Res Treat, 125 (3), 729-38
DOI 10.1007/s10549-010-0911-2, PubMed 20449649

Kamalakaran S, Varadan V, Giercksky Russnes HE, Levy D, Kendall J, Janevski A, Riggs M, Banerjee N, Synnestvedt M, Schlichting E, Kåresen R, Shama Prasada K, Rotti H, Rao R, Rao L, Eric Tang MH, Satyamoorthy K, Lucito R, Wigler M, Dimitrova N, Naume B, Borresen-Dale AL, Hicks JB (2010)
DNA methylation patterns in luminal breast cancers differ from non-luminal subtypes and can identify relapse risk independent of other clinical variables
Mol Oncol, 5 (1), 77-92
DOI 10.1016/j.molonc.2010.11.002, PubMed 21169070

Kåresen R (2010)
[Against organizational chaos?]
Tidsskr Nor Laegeforen, 130 (24), 2453
DOI 10.4045/tidsskr.10.1284, PubMed 21164581

Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Stromberg M, Wiedswang G, Kvalheim G, Karesen R, Nesland JM, Borresen-Dale AL, Sorlie T (2010)
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer (vol 1, pg 160, 2007)
Mol. Oncol., 4 (2), 169
DOI 10.1016/j.molonc.2010.01.003

Russnes HG, Vollan HKM, Lingjærde OC, Krasnitz A, Lundin P, Naume B, Sørlie T, Borgen E, Rye IH, Langerød A, Chin SF, Teschendorff AE, Stephens PJ, Månér S, Schlichting E, Baumbusch LO, Kåresen R, Stratton MP, Wigler M, Caldas C, Zetterberg A, Hicks J, Børresen-Dale AL (2010)
Genomic architecture characterizes tumor progression paths and fate in breast cancer patients
Sci Transl Med, 2 (38), 38ra47
DOI 10.1126/scitranslmed.3000611, PubMed 20592421

Sauer T, Ebeltoft K, Pedersen MK, Kåresen R (2010)
Liquid based material from fine needle aspirates from breast carcinomas offers the possibility of long-time storage without significant loss of immunoreactivity of estrogen and progesterone receptors
Cytojournal, 7, 24
DOI 10.4103/1742-6413.75665, PubMed 21298022

Publications 2009

Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM (2009)
Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count
Histol Histopathol, 24 (8), 1049-59
DOI 10.14670/HH-24.1049, PubMed 19554512

Kalager M, Kåresen R, Wist E (2009)
[Survival after breast cancer--differences between Norwegian counties]
Tidsskr Nor Laegeforen, 129 (24), 2595-600
DOI 10.4045/tidsskr.09.0024, PubMed 20029554

Kåresen R, Wist E (2009)
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo (3. utg.), 441 s.
BIBSYS 080553532, ISBN 978-82-05-38485-9

Park D, Kåresen R, Naume B, Synnestvedt M, Beraki E, Sauer T (2009)
The prognostic impact of occult nodal metastasis in early breast carcinoma
Breast Cancer Res Treat, 118 (1), 57-66
DOI 10.1007/s10549-009-0340-2, PubMed 19219629

Sagen A, Kåresen R, Risberg MA (2009)
Physical activity for the affected limb and arm lymphedema after breast cancer surgery. A prospective, randomized controlled trial with two years follow-up
Acta Oncol, 48 (8), 1102-10
DOI 10.3109/02841860903061683, PubMed 19863217

Sagen A, Kåresen R, Sandvik L, Risberg MA (2009)
Changes in arm morbidities and health-related quality of life after breast cancer surgery - a five-year follow-up study
Acta Oncol, 48 (8), 1111-8
DOI 10.3109/02841860903061691, PubMed 19863218

Sagen A, Kåresen R, Skaane P, Risberg MA (2009)
Validity for the simplified water displacement instrument to measure arm lymphedema as a result of breast cancer surgery
Arch Phys Med Rehabil, 90 (5), 803-9
DOI 10.1016/j.apmr.2008.11.016, PubMed 19406300

Publications 2008

Dhakal HP, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Bassarova A, Giercksky KE, Nesland JM (2008)
Vascularization in primary breast carcinomas: its prognostic significance and relationship with tumor cell dissemination
Clin Cancer Res, 14 (8), 2341-50
DOI 10.1158/1078-0432.CCR-07-4214, PubMed 18413823

Schou I, Ekeberg O, Karesen R, Sorensen E (2008)
Psychosocial intervention as a component of routine breast cancer care-who participates and does it help?
Psychooncology, 17 (7), 716-20
DOI 10.1002/pon.1264, PubMed 18033695

Publications 2007

Chanock SJ, Burdett L, Yeager M, Llaca V, Langerød A, Presswalla S, Kaaresen R, Strausberg RL, Gerhard DS, Kristensen V, Perou CM, Børresen-Dale AL (2007)
Somatic sequence alterations in twenty-one genes selected by expression profile analysis of breast carcinomas
Breast Cancer Res, 9 (1), R5
DOI 10.1186/bcr1637, PubMed 17224074

Langerød A, Zhao H, Borgan Ø, Nesland JM, Bukholm IR, Ikdahl T, Kåresen R, Børresen-Dale AL, Jeffrey SS (2007)
TP53 mutation status and gene expression profiles are powerful prognostic markers of breast cancer
Breast Cancer Res, 9 (3), R30
DOI 10.1186/bcr1675, PubMed 17504517

Naume B, Zhao X, Synnestvedt M, Borgen E, Russnes HG, Lingjaerde OC, Strømberg M, Wiedswang G, Kvalheim G, Kåresen R, Nesland JM, Børresen-Dale AL, Sørlie T (2007)
Presence of bone marrow micrometastasis is associated with different recurrence risk within molecular subtypes of breast cancer
Mol Oncol, 1 (2), 160-71
DOI 10.1016/j.molonc.2007.03.004, PubMed 19383292

Park D, Kåresen R, Axcrona U, Noren T, Sauer T (2007)
Expression pattern of adhesion molecules (E-cadherin, alpha-, beta-, gamma-catenin and claudin-7), their influence on survival in primary breast carcinoma, and their corresponding axillary lymph node metastasis
APMIS, 115 (1), 52-65
DOI 10.1111/j.1600-0463.2007.apm_524.x, PubMed 17223851

Park D, Kåresen R, Noren T, Sauer T (2007)
Ki-67 expression in primary breast carcinomas and their axillary lymph node metastases: clinical implications
Virchows Arch, 451 (1), 11-8
DOI 10.1007/s00428-007-0435-2, PubMed 17554555

Publications 2006

Schlichting E, Harr ME, Sauer T, Babovic A, Kåresen R (2006)
[Sentinel lymph node biopsy in breast cancer]
Tidsskr Nor Laegeforen, 126 (16), 2098-100
PubMed 16932777

Wiedswang G, Borgen E, Schirmer C, Kåresen R, Kvalheim G, Nesland JM, Naume B (2006)
Comparison of the clinical significance of occult tumor cells in blood and bone marrow in breast cancer
Int J Cancer, 118 (8), 2013-9
DOI 10.1002/ijc.21576, PubMed 16287086

Publications 2005

Kristensen VN, Sørlie T, Geisler J, Langerød A, Yoshimura N, Kåresen R, Harada N, Lønning PE, Børresen-Dale AL (2005)
Gene expression profiling of breast cancer in relation to estrogen receptor status and estrogen-metabolizing enzymes: clinical implications
Clin Cancer Res, 11 (2 Pt 2), 878s-83s
PubMed 15701881

Kåresen R (2005)
[Breast cancer surgery in Norway]
Tidsskr Nor Laegeforen, 125 (5), 555
PubMed 15776024

Kåresen R, Wist E (2005)
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo (2. utg.), 416 s.
BIBSYS 050216910, ISBN 978-82-05-33494-6

Sagen A, Kåresen R, Risberg MA (2005)
The reliability of a simplified water displacement instrument: a method for measuring arm volume
Arch Phys Med Rehabil, 86 (1), 86-9
DOI 10.1016/j.apmr.2003.12.042, PubMed 15640996

Publications 2004

Naume B, Wiedswang G, Borgen E, Kvalheim G, Karesen R, Quist H, Janbu J, Harbitz TB, Nesland JM (2004)
The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells
In Clinical cancer research, AACR Publications Department, Philadelphia, PA, 10(2004)9, S. 3091-7
BIBSYS 05181322x

Naume B, Wiedswang G, Borgen E, Kvalheim G, Kåresen R, Qvist H, Janbu J, Harbitz T, Nesland JM (2004)
The prognostic value of isolated tumor cells in bone marrow in breast cancer patients: evaluation of morphological categories and the number of clinically significant cells
Clin Cancer Res, 10 (9), 3091-7
DOI 10.1158/1078-0432.ccr-03-0373, PubMed 15131048

Schou I, Ekeberg Ø, Ruland CM, Sandvik L, Kåresen R (2004)
Pessimism as a predictor of emotional morbidity one year following breast cancer surgery
Psychooncology, 13 (5), 309-20
DOI 10.1002/pon.747, PubMed 15133772

Usary J, Llaca V, Karaca G, Presswala S, Karaca M, He X, Langerød A, Kåresen R, Oh DS, Dressler LG, Lønning PE, Strausberg RL, Chanock S, Børresen-Dale AL, Perou CM (2004)
Mutation of GATA3 in human breast tumors
Oncogene, 23 (46), 7669-78
DOI 10.1038/sj.onc.1207966, PubMed 15361840

Wiedswang G, Borgen E, Kåresen R, Qvist H, Janbu J, Kvalheim G, Nesland JM, Naume B (2004)
Isolated tumor cells in bone marrow three years after diagnosis in disease-free breast cancer patients predict unfavorable clinical outcome
Clin Cancer Res, 10 (16), 5342-8
DOI 10.1158/1078-0432.CCR-04-0245, PubMed 15328170

Zhao H, Langerød A, Ji Y, Nowels KW, Nesland JM, Tibshirani R, Bukholm IK, Kåresen R, Botstein D, Børresen-Dale AL, Jeffrey SS (2004)
Different gene expression patterns in invasive lobular and ductal carcinomas of the breast
Mol Biol Cell, 15 (6), 2523-36
DOI 10.1091/mbc.e03-11-0786, PubMed 15034139

Publications 2003

Kåresen R, Hervik A, Schlichting E (2003)
[Medical logistics: principles applied to diagnostics and therapy in women with symptoms and signs of breast cancer]
Tidsskr Nor Laegeforen, 123 (12), 1687-90
PubMed 12821992

Sauer T, Wiedswang G, Boudjema G, Christensen H, Karesen R (2003)
Assessment of HER-2/neu overexpression and/or gene amplification in breast carcinomas: should in situ hybridization be the method of choice?
APMIS, 111 (3), 444-50
DOI 10.1034/j.1600-0463.2003.t01-1-1110210.x, PubMed 12752225

Wiedswang G, Borgen E, Karesen R, Naume B (2003)
Detection of isolated tumor cells in BM from breast-cancer patients: significance of anterior and posterior iliac crest aspirations and the number of mononuclear cells analyzed
Cytotherapy, 5 (1), 40-5
DOI 10.1080/14653240310000065, PubMed 12745581

Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B (2003)
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
J Clin Oncol, 21 (18), 3469-78
DOI 10.1200/JCO.2003.02.009, PubMed 12972522

Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist HL, Schlichting E, Sauer T, Janbu J, Harbitz TB, Naume B (2003)
Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer
In Journal of clinical oncology, The Society, Alexandria VA, 21(2003)18, s.3469-78
BIBSYS 041728920

Yoshimura N, Harada N, Bukholm I, Kåresen R, Børresen-Dale AL, Kristensen VN (2003)
Intratumoural mRNA expression of genes from the oestradiol metabolic pathway and clinical and histopathological parameters of breast cancer
Breast Cancer Res, 6 (2), R46-55
DOI 10.1186/bcr746, PubMed 14979917

Publications 2002

Kåresen R, Jensen HH, Sauer T, Schlichting E, Skaane P, Wang H (2002)
Logistics of referral, diagnostic assessment and treatment of patients with breast symptoms and signs
Scand J Surg, 91 (3), 232-8
DOI 10.1177/145749690209100304, PubMed 12449464

Kåresen R, Varhaug JE, Gundersen S (2002)
Brystkreft: informasjon til pasienter, pårørende og andre interesserte
In Kreftinfo, Den norske kreftforening, Oslo, 2/2002 (8. oppl.), 28 s.
BIBSYS 022497145

Schou I, Ekeberg Ø, Ruland CM, Kåresen R (2002)
Do women newly diagnosed with breast cancer and consulting surgeon assess decision-making equally?
Breast, 11 (5), 434-41
DOI 10.1054/brst.2002.0454, PubMed 14965708

Publications 2001

Edwin B, Raeder I, Trondsen E, Kaaresen R, Buanes T (2001)
Outpatient laparoscopic adrenalectomy in patients with Conn's syndrome
Surg Endosc, 15 (6), 589-91
DOI 10.1007/s004640090021, PubMed 11591947

Ekeberg Ø, Skjauff H, Kåresen R (2001)
Screening for breast cancer is associated with a low degree of psychological distress
Breast, 10 (1), 20-4
DOI 10.1054/brst.2000.0177, PubMed 14965553

Jain AN, Chin K, Børresen-Dale AL, Erikstein BK, Eynstein Lonning P, Kaaresen R, Gray JW (2001)
Quantitative analysis of chromosomal CGH in human breast tumors associates copy number abnormalities with p53 status and patient survival
Proc Natl Acad Sci U S A, 98 (14), 7952-7
DOI 10.1073/pnas.151241198, PubMed 11438741

Kåresen R (2001)
Nasjonalt screeningsenter for kreft
Sosial- og helsedepartementet, [Oslo], 40 s.
BIBSYS 010182101

Lundgren S, Jørgensen S, Kåresen R (2001)
[Breast cancer surgery in Norway 1990-95 illustrated by data from SINTEF United]
Tidsskr Nor Laegeforen, 121 (23), 2688-93
PubMed 11699375

Naume B, Borgen E, Kvalheim G, Kåresen R, Qvist H, Sauer T, Kumar T, Nesland JM (2001)
Detection of isolated tumor cells in bone marrow in early-stage breast carcinoma patients: comparison with preoperative clinical parameters and primary tumor characteristics
Clin Cancer Res, 7 (12), 4122-9
PubMed 11751511

Wang H, Kåresen R, Hervik A, Thoresen SO (2001)
Mammography screening in Norway: results from the first screening round in four counties and cost-effectiveness of a modeled nationwide screening
Cancer Causes Control, 12 (1), 39-45
DOI 10.1023/a:1008999403069, PubMed 11227924

Wiedswang G, Naess AB, Naume B, Kåresen R (2001)
Micrometastasis to axillary lymph nodes and bone marrow in breast cancer patients
Breast, 10 (3), 237-42
DOI 10.1054/brst.2000.0245, PubMed 14965591

Publications 2000

Jacobsen U, Skaane P, Sauer T, Kåresen R (2000)
[Diagnostic and therapeutic localized breast biopsy]
Tidsskr Nor Laegeforen, 120 (5), 595-7
PubMed 10833920

Kristensen VN, Harada N, Yoshimura N, Haraldsen E, Lonning PE, Erikstein B, Kåresen R, Kristensen T, Børresen-Dale AL (2000)
Genetic variants of CYP19 (aromatase) and breast cancer risk
Oncogene, 19 (10), 1329-33
DOI 10.1038/sj.onc.1203425, PubMed 10713674

Kåresen R, Langmark F (2000)
[Psychological, social and economic situation of women surgically treated for cancer]
Tidsskr Nor Laegeforen, 120 (23), 2741-8
PubMed 11107917

Kåresen R, Wist E (2000)
Kreftsykdommer: en basisbok for helsepersonell
Gyldendal akademisk, Oslo, 400 s.
BIBSYS 000586978, ISBN 82-00-45260-3

Laake K, Vu P, Andersen TI, Erikstein B, Kåresen R, Lonning PE, Skovlund E, Børresen-Dale AL (2000)
Screening breast cancer patients for Norwegian ATM mutations
Br J Cancer, 83 (12), 1650-3
DOI 10.1054/bjoc.2000.1519, PubMed 11104561

Wang H, Jebsen PW, Kåresen R, Thoresen SO (2000)
Ductal carcinoma in situ of the breast--a review of diagnosis, treatment and outcome in a hospital-based Norwegian series
Acta Oncol, 39 (2), 131-4
DOI 10.1080/028418600430662, PubMed 10859000

Publications 1999

Buanes T, Karesen R, Geitung JT, Eide K, Rotnes JS (1999)
Experience with telesurgery and radiology via an ATM network
Int. Congr. Ser., 1191, 541-544

Kristensen VN, Haraldsen EK, Anderson KB, Lonning PE, Erikstein B, Karesen R, Gabrielsen OS, Borresen-Dale AL (1999)
CYP17 and breast cancer risk: The polymorphism in the 5 ' flanking area of the gene does not influence binding to Sp-1
Cancer Res., 59 (12), 2825-2828

Kåresen R, Bø JK, Haustveit S, Hervik A, Thoresen SO (1999)
[Cost-effectiveness of mammography screening in Norway]
Tidsskr Nor Laegeforen, 119 (24), 3553-9
PubMed 10563171

Kåresen R, Jacobsen U, Sauer T, Skaane P (1999)
[A prospective registration of diagnosis and treatment of breast tumors at the Ulleval hospital 1988-1995]
Tidsskr Nor Laegeforen, 119 (24), 3562-6
PubMed 10563172

Kåresen R, Langmark F (1999)
Caring about women and cancer: resultater fra en landsdekkende undersøkelse våren 1997
Kreftregisteret, [Oslo, [upag.]
BIBSYS 040889653

Nedelcheva Kristensen V, Haraldsen EK, Anderson KB, Lønning PE, Erikstein B, Kåresen R, Gabrielsen OS, Børresen-Dale AL (1999)
CYP17 and breast cancer risk: the polymorphism in the 5' flanking area of the gene does not influence binding to Sp-1
Cancer Res, 59 (12), 2825-8
PubMed 10383140

Schlichting E, Babovic A, Kåresen R (1999)
[Sentinel lymph node]
Tidsskr Nor Laegeforen, 119 (14), 2009
PubMed 10394273

Schou I, Kåresen R, Lensby A (1999)
[Follow-up of women surgically treated for breast cancer]
Tidsskr Nor Laegeforen, 119 (24), 3567-9
PubMed 10563173

Publications 1998

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1998)
E-cadherin and alpha-, beta-, and gamma-catenin protein expression in relation to metastasis in human breast carcinoma
J Pathol, 185 (3), 262-6
DOI 10.1002/(SICI)1096-9896(199807)185:3<262::AID-PATH97>3.0.CO;2-Y, PubMed 9771479

Enger H, Pettersen EH, Schlichting E, Kåresen R, Guldvog I, Sauer T (1998)
[Breast conserving surgery for breast cancer--local recurrence]
Tidsskr Nor Laegeforen, 118 (21), 3262-5
PubMed 9772812

Kåresen R, Schlichting E, Wist E (1998)
Brystkreft: en informasjonsbok for pasienter og pårørende
Universitetsforl., Oslo, 170 s.
BIBSYS 982362595, ISBN 82-00-42576-2

Moller P, Maehle L, Heimdal K, Dorum A, Apold J, Engebretsen LF, Kaurin RM, Jorgensen OG, Helgerud P, Qvist H, Bjorndal H, Kullmann G, Bohler P, Nysted A, Soreide JA, Varhaug JE, Aas T, Fjosne HE, Hagen A, Due J, Karesen R, Formoe E, Malme PA, Stedjeberg JO, Svenningsen SS et al. (1998)
Prospective findings in breast cancer kindreds: annual incidence rates according to age, stage at diagnosis, mean sojourn time, and incidence rates for contralateral cancer
Breast, 7 (1), 55-59
DOI 10.1016/S0960-9776(98)90053-4

Naume B, Borgen E, Nesland JM, Beiske K, Gilen E, Renolen A, Ravnås G, Qvist H, Kåresen R, Kvalheim G (1998)
Increased sensitivity for detection of micrometastases in bone-marrow/peripheral-blood stem-cell products from breast-cancer patients by negative immunomagnetic separation
Int J Cancer, 78 (5), 556-60
DOI 10.1002/(sici)1097-0215(19981123)78:5<556::aid-ijc5>3.0.co;2-g, PubMed 9808522

Sauer T, Beraki E, Jebsen PW, Amlie E, Harbitz T, Karesen R, Naess O (1998)
Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas - Results on six years of material and correlation with biochemical assay
Anal. Quant. Cytol. Histol., 20 (2), 122-126

Sauer T, Beraki E, Jebsen PW, Amlie E, Harbitz T, Kåresen R, Naess O (1998)
Assessing estrogen and progesterone receptor status in fine needle aspirates from breast carcinomas. Results on six years of material and correlation with biochemical assay
Anal Quant Cytol Histol, 20 (2), 122-6
PubMed 9569969

Schlichting E, Kåresen R (1998)
Brystkreft: diagnose, behandling og kontroller
Ullevål sykehus, Oslo, 19 s.
BIBSYS 981950647

Publications 1997

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1997)
Interaction between bcl-2 and p21 (WAF1/CIP1) in breast carcinomas with wild-type p53
Int J Cancer, 73 (1), 38-41
DOI 10.1002/(sici)1097-0215(19970926)73:1<38::aid-ijc7>3.0.co;2-2, PubMed 9334807

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen-Dale AL (1997)
Expression of E-cadherin and its relation to the p53 protein status in human breast carcinomas
Virchows Arch, 431 (5), 317-21
DOI 10.1007/s004280050105, PubMed 9463572

Bukholm IK, Nesland JM, Kåresen R, Jacobsen U, Børresen AL (1997)
Relationship between abnormal p53 protein and failure to express p21 protein in human breast carcinomas
J Pathol, 181 (2), 140-5
DOI 10.1002/(SICI)1096-9896(199702)181:2<140::AID-PATH745>3.0.CO;2-A, PubMed 9120716

Kåresen R (1997)
[Continuing surgical education]
Tidsskr Nor Laegeforen, 117 (20), 2992-3
PubMed 9340863

Kåresen R (1997)
[Breast cancer]
Tidsskr Nor Laegeforen, 117 (26), 3763-4
PubMed 9417676

Kåresen R, Linnestad P (1997)
[Efficiency based financing from the point of view of the physician-in-chief]
Tidsskr Nor Laegeforen, 117 (19), 2822-4
PubMed 9312877

Laake K, Odegård A, Andersen TI, Bukholm IK, Kåresen R, Nesland JM, Ottestad L, Shiloh Y, Børresen-Dale AL (1997)
Loss of heterozygosity at 11q23.1 in breast carcinomas: indication for involvement of a gene distal and close to ATM
Genes Chromosomes Cancer, 18 (3), 175-80
DOI 10.1002/(SICI)1098-2264(199703)18:3<175::AID-GCC4>3.3.CO;2-R, PubMed 9071570

Raabe NK, Fosså SD, Kåresen R (1997)
[Primary invasive breast cancer in Oslo 1980-89. A population based study of 1942 unselected patients treated by radical surgery]
Tidsskr Nor Laegeforen, 117 (26), 3778-83
PubMed 9417680

Raabe NK, Kaaresen R, Fossaa SD (1997)
Hospital-related differences in breast cancer management. Analysis of an unselected population-based series of 1353 radically operated patients
Breast Cancer Res Treat, 43 (3), 225-35
DOI 10.1023/a:1005730327487, PubMed 9150902

Raabe NK, Kaaresen R, Fosså SD (1997)
Analysis of adjuvant treatment in postmenopausal patients with stage II invasive breast carcinoma--a pattern of care study and quality assurance of 431 consecutive patients in Oslo 1980-1989
Acta Oncol, 36 (3), 255-60
DOI 10.3109/02841869709001259, PubMed 9208893

Raabe NK, Schistad O, Sauer T, Bofin A, Kaaresen R, Fossaa SD (1997)
Prognosis of radically operated breast carcinoma patients. A retrospective study of 167 consecutive patients with emphasis on histopathological grading, reproducibility and mean nuclear area
APMIS, 105 (5), 363-70
DOI 10.1111/j.1699-0463.1997.tb00582.x, PubMed 9201237

Publications 1996

Møller P, Maehle L, Heimdal K, Dørum A, Tretli S, Helgerud P, Quist H, Bjørndal H, Kåresen R, Nysted A, Varhaug JE, Fjøsne HE, Guleng RJ, Due J, Bøhler P, Giercksky KE, Tropé C, Kvinnsland S (1996)
Inherited breast carcinoma--prospective findings in 1,194 women at risk
Acta Oncol, 35 Suppl 8, 7-11
DOI 10.3109/02841869609098515, PubMed 9073043

Publications 1995

Kåresen R, Thoresen SO (1995)
[Mammography in Norway]
Nord Med, 110 (8-9), 224-5
PubMed 7478974

Skaane P, Kåresen R, Jacobsen U, Amlie E, Sauer T, Skjørten F (1995)
[Investigation of palpable breast tumours. Patient flow and quality assessment of the tripple diagnostic procedure]
Tidsskr Nor Laegeforen, 115 (16), 1965-9
PubMed 7638852

Publications 1994

Sauer T, Naess O, Kåresen R, Jacobsen U, Amlie E, Haug E (1994)
[Determination of estrogen receptors in aspirates from needle biopsies of breast carcinomas. Correlation to a biochemical method]
Tidsskr Nor Laegeforen, 114 (9), 1053-5
PubMed 8009516

Publications 1993

Hauer-Jensen M, Karesen R, Nygaard K, Solheim K, Amlie EJ, Havig O, Rosseland AR (1993)
Prospective randomized study of routine intraoperative cholangiography during open cholecystectomy: long-term follow-up and multivariate analysis of predictors of choledocholithiasis
Surgery, 113 (3), 318-23
PubMed 8441966

Kvinnsland S, Kåresen R, Lønning PE, Søreide JA (1993)
[Mistletoe in the treatment of cancer]
Tidsskr Nor Laegeforen, 113 (18), 2284-5
PubMed 7741807

Kåresen R, Skaane P, Skjørten F (1993)
[Microductectomy. A simple method for excision of intraductal changes in the breast]
Tidsskr Nor Laegeforen, 113 (10), 1233-5
PubMed 8493656

Løvig T, Haffner JF, Kaaresen R, Nygaard K, Stadaas JO (1993)
Gastric banding for morbid obesity: five years follow-up
Int J Obes Relat Metab Disord, 17 (8), 453-7
PubMed 8401747

Publications 1992

Iversen JR, Amlie E, Hagen S, Harbitz T, Kåresen R, Rø J (1992)
[Late diagnosis of advanced breast cancer--a challenge for health services]
Tidsskr Nor Laegeforen, 112 (14), 1821-4
PubMed 1631840

Jacobsen U, Kåresen R (1992)
A microcomputer-based structured journal system for diseases of the female mammary gland
Med Inform (Lond), 17 (3), 141-7
DOI 10.3109/14639239209096530, PubMed 1405836

Solheim K, Kåresen R, Carlsen E, Buanes T, Pillgram-Larsen J (1992)
[Quality assurance in a surgical department]
Tidsskr Nor Laegeforen, 112 (26), 3314-7
PubMed 1471108

Publications 1991

Arnesen KE, Erikssen J, Gavelstad OJ, Kåresen R, Rolstad K, Søreide O, Vandeskog G, Odegaard E (1991)
[Reports of waiting list data from hospitals to the central registry--a database for reducing hospital waiting lists. Minimum dataset of waiting list parameters]
Tidsskr Nor Laegeforen, 111 (29), 3536-9
PubMed 1796444

Arnesen KE, Erikssen J, Kåresen R, Søreide O (1991)
[Content, function and structure of standardized hospital waiting lists in Norway]
Tidsskr Nor Laegeforen, 111 (29), 3526-30
PubMed 1796442

Arnesen KE, Erikssen J, Kåresen R, Søreide O (1991)
[Grouping and calculated measurements of standardized waiting lists in Norway. Definitions and interpretations of waiting lists]
Tidsskr Nor Laegeforen, 111 (29), 3531-5
PubMed 1796443

Skjørten F, Kaaresen R, Jacobsen U, Skaane P, Amlie E (1991)
Nuclear morphometry of benign and malignant breast lesions
Eur J Surg Oncol, 17 (4), 350-3
PubMed 1874292

Publications 1990

Arnesen KE, Søreide O, Kåresen R, Erikssen J (1990)
Standardisering av informasjon fra ventelister ved avdeling og poliklinikk ved sykehus: rapport til sosialdepartementets gruppe for moderniseringog effektivisering.
Sentralsykehuset I Akershus, Lørenskog (rev. utg.), 82 s. + VEDLEGG
BIBSYS 040577198

Kåresen R (1990)
[Breast conserving surgery--a good treatment of breast cancer?]
Tidsskr Nor Laegeforen, 110 (2), 185-6
PubMed 2300951

Skjørten FJ, Skaane P, Jacobsen U, Kaaresen R, Haaheim LL (1990)
The histopathology of non-palpable breast lesions detected by clinical mammography
Eur J Surg Oncol, 16 (6), 475-80
PubMed 2253791

Publications 1989

Andersson M, Aronsen KF, Balch C, Domellöf L, Eksborg S, Hafström LO, Howell SB, Kåresen R, Midander J, Teder H (1989)
Pharmacokinetics of intra-arterial mitomycin C with or without degradable starch microspheres (DSM) in the treatment of non-resectable liver cancer
Acta Oncol, 28 (2), 219-22
DOI 10.3109/02841868909111250, PubMed 2500141

Gerner T, Nygaard K, Kaaresen R, Mjoerud J, Larsen S (1989)
Antibiotic prophylaxis in colorectal surgery. Combined doxycycline-tinidazole vs. doxycycline alone
Acta Chir Scand, 155 (2), 121-4
PubMed 2662688

Jacobsen U, Kåresen R, Skaane P, Skjennald A, Skjörten F (1989)
Out-patient surgical biopsy for nonpalpable breast lesions. Technique, results and consequences
Acta Chir Scand, 155 (6-7), 313-6
PubMed 2816214

Skjennald A, Heldaas J, Henjum A, Kåresen R (1989)
Transhepatic endoprosthesis and surgical anastomosis in the palliative treatment of bile duct obstructions
Eur J Radiol, 9 (3), 167-8
PubMed 2478365

Sletnes KE, Wisløff F, Schlichting E, Kåresen R (1989)
[Splenectomy in hematologic diseases]
Tidsskr Nor Laegeforen, 109 (2), 201-3
PubMed 2916199

Publications 1988

Hallgrimsson P, Kåresen R, Artun K, Skjennald A (1988)
Non-palpable breast lesions. Diagnostic criteria and preoperative localization
Acta Radiol, 29 (3), 285-8
PubMed 2968096

Kåresen R, Hagen S, Skjørten F, Skaane P (1988)
[Examination and treatment of breast cancer. Where are we today?]
Tidsskr Nor Laegeforen, 108 (25), 2020-2
PubMed 3201411

Schlichting E, Solheim K, Kåresen R (1988)
[Splenectomy. Indications and complications]
Tidsskr Nor Laegeforen, 108 (2), 127-9
PubMed 3353908

Publications 1987

Käresen R, Hagen S (1987)
[Atypical epithelial hyperplasias, ductal and lobular carcinoma in situ. Treatment, follow-up and prognosis]
Tidsskr Nor Laegeforen, 107 (9), 859-60, 865
PubMed 3035745

Publications 1986

Andersen GP, Buanes T, Kåresen R (1986)
[Alcohol consumption of patients admitted with acute injuries requiring surgery]
Tidsskr Nor Laegeforen, 106 (32), 2718-9, 2742
PubMed 3810593

Hauer-Jensen M, Kåresen R, Nygaard K, Solheim K, Amlie E, Havig O, Viddal KO (1986)
Consequences of routine peroperative cholangiography during cholecystectomy for gallstone disease: a prospective, randomized study
World J Surg, 10 (6), 996-1002
DOI 10.1007/BF01658656, PubMed 3798950

Jensen MH, Kåresen R, Nygaard K, Solheim K, Amlie E, Havig O, Viddal KO (1986)
[Peroperative cholangiography in elective cholecystectomy]
Tidsskr Nor Laegeforen, 106 (19-21), 1559-61
PubMed 3764830

Aabakken L, Kåresen R, Serck-Hanssen A, Osnes M (1986)
Transpapillary biopsies and brush cytology from the common bile duct
Endoscopy, 18 (2), 49-51
DOI 10.1055/s-2007-1018325, PubMed 3956437

Aasen AO, Ruud TE, Kaaresen R, Stadaas JO (1986)
Evaluation of patients with acute pancreatitis by means of chromogenic peptide substrate assays and the proenzyme functional inhibition index
Scand J Gastroenterol Suppl, 126, 40-5
DOI 10.3109/00365528609091891, PubMed 3470917

Publications 1985

Andersen GP, Buanes T, Kåresen R (1985)
[Acute traumatology/orthopedics at the Ullevål hospital]
Tidsskr Nor Laegeforen, 105 (4), 287-90
PubMed 3983924

Buanes T, Andersen GP, Graadal O, Kåresen R, Fjellskaalnes E (1985)
[Emergency hospitalization in a surgical department. A prospective study of treatment routines and resource consumption]
Tidsskr Nor Laegeforen, 105 (4), 283-7
PubMed 3983923

Buanes T, Andersen GP, Kåresen R (1985)
[Acute gastroenterological surgery at the Ullevål hospital]
Tidsskr Nor Laegeforen, 105 (4), 291-4
PubMed 3983925

Buanes T, Andersen GP, Kåresen R (1985)
[Use of analgesics in surgical emergency patients]
Tidsskr Nor Laegeforen, 105 (4), 302-4
PubMed 3983928

Buanes T, Andersen GP, Kåresen R (1985)
[Cooperation between primary health care providers and hospitals. A prospective study from the Surgical Department of the Ullevål Hospital, with special reference to hospitalization practices and procedures for surgical admissions]
Tidsskr Nor Laegeforen, 105 (4), 308-11
PubMed 3983930

Hauer-Jensen M, Kåresen R, Nygaard K, Solheim K, Amlie E, Havig O, Viddal KO (1985)
Predictive ability of choledocholithiasis indicators. A prospective evaluation
Ann Surg, 202 (1), 64-8
DOI 10.1097/00000658-198507000-00010, PubMed 4015213

Publications 1982

Flaten O, Hanssen LE, Kåresen R, Aune S, Myren J (1982)
Glucose-induced release of neurotensin after gastric surgery
Digestion, 24 (2), 94-7
DOI 10.1159/000198782, PubMed 7128961

Flaten O, Hanssen LE, Kåresen R, Aune S, Myren J (1982)
Intestinal phase release of pancreatic polypeptide (PP) after oral glucose in patients with gastric resection
Horm Metab Res, 14 (11), 613-4
DOI 10.1055/s-2007-1019096, PubMed 7152475

Kåresen R, Eliassen G, Natvig NL, Sager EM (1982)
[Suspected non-palpable changes in the breast diagnosed by mammography. Treatment planning and therapeutical problems]
Tidsskr Nor Laegeforen, 102 (17-18), 960-4
PubMed 6297119

Natvig NL, Sager EM, Kåresen R (1982)
[Suspected non-palpable changes in the breast diagnosed by mammography. Radiological biopsy criteria and technic in marking the biopsy area]
Tidsskr Nor Laegeforen, 102 (17-18), 956-9
PubMed 6297118

Publications 1981

Kåresen R, Serch-Hanssen A, Thoresen BO, Hertzberg J (1981)
Crohn's disease: long-term results of surgical treatment
Scand J Gastroenterol, 16 (1), 57-64
PubMed 7233081

TRONIER B, KARESEN R, AUNE S (1981)
GLUCAGON IMMUNOREACTIVITY IN MAN AFTER PANCREAS RESECTION AND TOTAL PANCREATECTOMY MEASURED BY DIFFERENT ANTISERA
Horm. Metab. Res., 13 (1), 56-57
DOI 10.1055/s-2007-1019167

Publications 1980

Hanssen LE, Kåresen R, Aune S (1980)
The effect of glucose on plasma immunoreactive secretin in normal man and after gastrectomy or pancreatectomy
Scand J Gastroenterol, 15 (4), 471-9
DOI 10.3109/00365528009181503, PubMed 7001613

Kåresen R, Hertzberg J, Johannesen J, Thoresen BO, Orjasaeter H (1980)
Carcinoembryonic antigen in the diagnosis and follow-up of colorectal carcinoma
Am J Proctol Gastroenterol Colon Rectal Surg, 31 (11), 18-22
PubMed 7212050

Kåresen R, Tronier B, Aune S (1980)
Immunoreactive glucagon and insulin C-peptide in man after resection of the pancreas and total pancreatectomy
Am J Surg, 140 (2), 272-6
DOI 10.1016/0002-9610(80)90021-5, PubMed 6996505

Publications 1979

Hanssen LE, Kåresen R, Aune S (1979)
Immunoreactive secretin release in patients after duodenectomy and partial or total pancreatectomy
Scand J Gastroenterol, 14 (8), 997-1000
PubMed 43589

Publications 1974

KARESEN R (1974)
IMMUNE-REACTION AGAINST MALIGNANT-MELANOMA STUDIES IN A BIOPSY MATERIAL
ACTA PATH MICRO IM A, A 82 (1), 116-126

Kåresen R (1974)
The immune reaction against malignant melanoma studied in a biopsy material
Acta Pathol Microbiol Scand A, 82 (1), 116-26
DOI 10.1111/j.1699-0463.1974.tb03833.x, PubMed 4133272

Publications 1971

Kåresen R (1971)
[Immune reactions against human malignant tumors]
Tidsskr Nor Laegeforen, 91 (35), 2555-60
PubMed 4109664

Kåresen R (1971)
Thyroid immunity: studies on the effect of anti-thyroglobulin antibodies inthe guinea-pig
Oslo, 1 b. (flere pag.)
BIBSYS 940231093

Publications 1970

Godal T, Kåresen R, Seljelid R (1970)
[Hypothyroidism after thyroidectomy for nontoxic goiter]
Tidsskr Nor Laegeforen, 90 (18), 1690-2
PubMed 5458880

Kåresen R (1970)
Thyroid eosinophilia and cutaneous Arthus reaction simultaneously induced in the guinea-pig by antiserum to thyroglobulin
Acta Pathol Microbiol Scand B Microbiol Immunol, 78 (4), 435-43
DOI 10.1111/j.1699-0463.1970.tb04325.x, PubMed 4249611

Kåresen R (1970)
Induction of thyroiditis in guinea-pigs by intravenous injection of rabbit anti-guinea-pig thyroglobulin serum. 3. Electron microscopic study
Immunology, 19 (2), 301-18
PubMed 5470196

Kåresen R (1970)
Experimental allergic thyroiditis in the guinea-pig. A light, fluorescence and electron microscopic study, with particular reference to the migration of lymphocytes through the vessel walls
Acta Pathol Microbiol Scand A, 78 (6), 625-48
PubMed 5499386

Kåresen R (1970)
The effect of repeated injections of rabbit anti-guinea-pig thyroglobulin serum into guinea-pigs
Acta Pathol Microbiol Scand A, 78 (6), 649-57
DOI 10.1111/j.1699-0463.1970.tb03516.x, PubMed 5499387

Publications 1969

Kåresen R, Godal T (1969)
Induction of thyroiditis in guinea-pigs by intravenous injection of rabbit anti-guinea-pig thyroglobulin serum. I. Light microscopic study
Immunology, 17 (6), 847-61
PubMed 4195527

Kåresen R, Godal T (1969)
Induction of thyroiditis in guinea-pigs by intravenous injection of rabbit anti-guinea-pig thyroglobulin serum. II. Studies with fluorescent antibody technique
Immunology, 17 (6), 863-74
PubMed 4195528